Core Insights - Public fund subscription restrictions have been adjusted in November, allowing institutional clients to purchase or make large subscriptions for high-performing products with over 10% net value growth this year [1][2] - The adjustments reflect a positive outlook on the A-share market, with fund companies believing that quality assets are currently undervalued and present high investment value [2] Group 1: Fund Performance and Adjustments - Ten funds, including E Fund Rui Xiang Mixed I and Guojin Quantitative Multi-Strategy A, have lifted restrictions on large subscriptions due to their net value growth exceeding 10% this year [1] - For instance, Changcheng Fund announced the resumption of large subscriptions for Changcheng Medical Industry Selected Mixed Fund, which has a year-to-date net value growth rate of 78.68% as of November 7 [1] Group 2: Market Sentiment and Strategy - The lifting of subscription limits indicates fund managers' confidence in their research capabilities and the ability to capture structural opportunities in the market [2] - Recently relaxed funds are primarily active equity funds with medium to high elasticity, alongside some quantitative strategy products, focusing on balanced allocation and low volatility [2] Group 3: Investment Strategies - Investors are advised to consider the past management capabilities of fund managers and the stability of performance post-expansion [2] - It is recommended to align investments with personal risk preferences, as products in sectors like pharmaceuticals and quantitative strategies may exhibit higher volatility [2] - Caution is advised regarding "scale traps," where a rapid increase in fund size could impact strategy effectiveness, necessitating ongoing monitoring of size changes [2]